Moreover, metformin may improve tumor oxygenation by selectively killing hypoxic cells through the suppression of the mammalian target of rapamycin (mTOR) pathway and modulation of the unfolded protein response (UPR), both important for cell survival under hypoxic conditions [11, 12]. The gene discussed is MTOR; the disease is neoplasm.